首页> 美国卫生研究院文献>Cardiovascular Diabetology >Long-term effects of peroxisome proliferator-activated receptor ligand bezafibrate on N-terminal pro-B type natriuretic peptide in patients with advanced functional capacity impairment

【2h】

Long-term effects of peroxisome proliferator-activated receptor ligand bezafibrate on N-terminal pro-B type natriuretic peptide in patients with advanced functional capacity impairment

机译：过氧化物酶体增殖物激活受体配体苯扎贝特对晚期功能能力减退患者N端pro-B型利钠肽的长期影响

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

BackgroundThe effects of pan-peroxisome proliferator-activated receptor (PPAR) ligand bezafibrate on N-terminal pro-B type natriuretic peptide (ProBNP) level in patients with coronary artery disease (CAD) is unknown. The current study aimed to investigate the long-term effects of bezafibrate on ProBNP level in patients with pre-existing CAD and advanced functional capacity impairment.

机译：背景泛过氧化物酶体增殖物激活受体（PPAR）配体苯扎贝特对冠心病（CAD）患者的N端pro-B型利钠肽（ProBNP）水平的影响尚不清楚。当前的研究旨在调查苯扎贝特对已有CAD和晚期功能能力受损的患者ProBNP水平的长期影响。

著录项

期刊名称 Cardiovascular Diabetology
作者
Koichi Node; Teruo Inoue; Valentin Boyko; Ilan Goldberg; Enrique Z Fisman; Yehuda Adler; Ehud Schwammenthal; Zipora Matas; Solomon Behar; Alexander Tenenbaum;
展开▼
作者单位

展开▼
年(卷),期 2009(8),-1
年度 2009
页码 5
总页数 7
原文格式 PDF
正文语种
中图分类心血管疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Long-term effects of peroxisome proliferator-activated receptor ligand bezafibrate on N-terminal pro-B type natriuretic peptide in patients with advanced functional capacity impairment [J] . Koichi Node, Teruo Inoue, Valentin Boyko, Cardiovascular Diabetology . 2009,第1期

机译：过氧化物酶体增殖物激活受体配体苯扎贝特对晚期功能能力减退患者N端pro-B型利钠肽的长期影响
2. Pre-Procedural N-Terminal Pro-B Type Natriuretic Peptide Predicts Contrast-Induced Acute Kidney Injury and Long-Term Outcome in Elderly Patients After Elective Percutaneous Coronary Intervention [J] . Kai-yang Lin, Zhi-yong Wu, Zhe-bin You, International heart journal . 2018,第5期

机译：术前N端Pro-B型利尿钠肽可预测选择性行经皮冠状动脉介入治疗后老年患者的造影剂诱发的急性肾损伤和长期结果。
3. B-type natriuretic peptide versus amino terminal pro-B type natriuretic peptide: selecting the optimal heart failure marker in patients with impaired kidney function [J] . Lena Jafri, Waqar Kashif, Javed Tai, BMC Nephrology . 2013,第1期

机译：B型利钠肽与氨基端B型利尿肽：选择肾功能受损患者的最佳心力衰竭标志物
4. CARDIAC BIOMARKERS TROPONIN I AND N-TERMINAL PRO-B-TYPE NATRIURETIC PEPTIDE IN CANINE CHRONIC KIDNEY DISEASE PATIENTS [C] . Lena Pelander, Jens Haggstrom, Ingrid Ljungvall Conference of the American^College^of^Veterinary^Internal^Medicine . 2016

机译：Canine慢性肾病患者的心脏生物标志物肌钙蛋白I和N-末端Pro-B型利钠尿肽
5. The Association between Depressive Symptoms and N-terminal pro-B type natriuretic peptide with Functional Status in Patients with Heart Failure [O] . Zyad T. Saleh, Jia-Rong Wu, Ibrahim Salami, -1

机译：心力衰竭患者抑郁症状与N端pro-B型利尿钠肽与功能状态的关系
6. Long-term effects of peroxisome proliferator-activated receptor ligand bezafibrate on N-terminal pro-B type natriuretic peptide in patients with advanced functional capacity impairment [O] . 2009

机译：过氧化物酶体增殖物激活受体配体苯扎贝特对晚期功能能力减退患者N端pro-B型利钠肽的长期影响

Long-term effects of peroxisome proliferator-activated receptor ligand bezafibrate on N-terminal pro-B type natriuretic peptide in patients with advanced functional capacity impairment

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅